Table_4.xls (9.5 kB)

Perinatal and neonatal outcomes for HIV+ (n = 63) and HIV- (n = 42) maternal infant pairs.

dataset

posted on 2015-08-06, 04:00 authored by Deborah M. Money, Emily C. Wagner, Evelyn J. Maan, Tessa Chaworth-Musters, Izabelle Gadawski, Julie E. van Schalkwyk, John C. Forbes, David R. Burdge, Arianne Y. K. Albert, Zoe Lohn, Hélène C. F. Côté

^a One infant born to an HIV- mother was stillborn.

^b Two HIV- control women were considered at high risk of contracting HIV due to drug use and unprotected intercourse with partners with unknown HIV status; therefore, infants were treated with zidovudine (ZDV) and nevirapine (NVP) as per standard of care.

^c Maternal HIV+ group: pulmonary artery stenosis (n = 2), pyloric stenosis (n = 1), hydronephrosis (n = 1); Maternal HIV- group: hydronephrosis (n = 1).

^d Maternal HIV+ group: mild respiratory distress (n = 1), respiratory syncytial virus (RSV) infection (n = 1), seizures (n = 1), sepsis (n = 1), apnoea of prematurity (n = 1), pneumonia (n = 1); Maternal HIV- group: mild respiratory distress (n = 1), neonatal intensive care unit for >24 hours (n = 1), hyperbilirubinaemia (n = 1).

Continuous variables were tested for differences between the groups using t-tests; Apgar scores were compared using a Wilcoxon rank-sum test; categorical variables were compared using Chi Squared tests or Fisher exact tests where appropriate.

SD, standard deviation

Perinatal and neonatal outcomes for HIV+ (n = 63) and HIV- (n = 42) maternal infant pairs.